Wednesday, 17 March 2010

Magnesium AL




Magnesium AL may be available in the countries listed below.


Ingredient matches for Magnesium AL



Magnesium Oxide

Magnesium Oxide light (a derivative of Magnesium Oxide) is reported as an ingredient of Magnesium AL in the following countries:


  • Germany

International Drug Name Search

Propofol Lipomed Fresenius




Propofol Lipomed Fresenius may be available in the countries listed below.


Ingredient matches for Propofol Lipomed Fresenius



Propofol

Propofol is reported as an ingredient of Propofol Lipomed Fresenius in the following countries:


  • Spain

International Drug Name Search

Tuesday, 16 March 2010

Hokunalin




Hokunalin may be available in the countries listed below.


Ingredient matches for Hokunalin



Tulobuterol

Tulobuterol is reported as an ingredient of Hokunalin in the following countries:


  • Japan

International Drug Name Search

Sunday, 14 March 2010

Sandoz Paroxetine




Sandoz Paroxetine may be available in the countries listed below.


Ingredient matches for Sandoz Paroxetine



Paroxetine

Paroxetine is reported as an ingredient of Sandoz Paroxetine in the following countries:


  • South Africa

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Sandoz Paroxetine in the following countries:


  • Canada

International Drug Name Search

Saturday, 13 March 2010

Remex




Remex may be available in the countries listed below.


Ingredient matches for Remex



Acyclovir

Aciclovir is reported as an ingredient of Remex in the following countries:


  • France

International Drug Name Search

Balsam Peru/Castor Oil/Trypsin Ointment


Pronunciation: BAL-sum pe-ROO/KAS-tor oil/TRIP-sin
Generic Name: Balsam Peru/Castor Oil/Trypsin
Brand Name: Xenaderm


Balsam Peru/Castor Oil/Trypsin Ointment is used for:

Treating skin wounds and promoting wound healing.


Balsam Peru/Castor Oil/Trypsin Ointment is a wound agent. It works by stimulating blood vessel activity and removal of unhealthy tissue. The castor oil works as a lubricant to protect the tissue.


Do NOT use Balsam Peru/Castor Oil/Trypsin Ointment if:


  • you are allergic to any ingredient in Balsam Peru/Castor Oil/Trypsin Ointment

Contact your doctor or health care provider right away if any of these apply to you.



Before using Balsam Peru/Castor Oil/Trypsin Ointment:


Some medical conditions may interact with Balsam Peru/Castor Oil/Trypsin Ointment. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a wound that contains a certain type of fresh blood clot

Some MEDICINES MAY INTERACT with Balsam Peru/Castor Oil/Trypsin Ointment. Because little, if any, of Balsam Peru/Castor Oil/Trypsin Ointment is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Balsam Peru/Castor Oil/Trypsin Ointment may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Balsam Peru/Castor Oil/Trypsin Ointment:


Use Balsam Peru/Castor Oil/Trypsin Ointment as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Clean the wound before applying Balsam Peru/Castor Oil/Trypsin Ointment.

  • Apply a thin film of Balsam Peru/Castor Oil/Trypsin Ointment to the affected area. The wound may be left unbandaged or an appropriate dressing may be applied as directed by your doctor.

  • To remove, wash gently with water.

  • Wash your hands immediately after using Balsam Peru/Castor Oil/Trypsin Ointment, unless your hands are part of the treated area.

  • Balsam Peru/Castor Oil/Trypsin Ointment is for external use only. Avoid getting Balsam Peru/Castor Oil/Trypsin Ointment in the eyes, nostrils, or mouth.

  • If you miss a dose of Balsam Peru/Castor Oil/Trypsin Ointment, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Balsam Peru/Castor Oil/Trypsin Ointment.



Important safety information:


  • Balsam Peru/Castor Oil/Trypsin Ointment may cause harm if it is swallowed. If you may have taken it by mouth, contact your poison control center or emergency room right away.

  • It may take several days for Balsam Peru/Castor Oil/Trypsin Ointment to work. Do not stop using Balsam Peru/Castor Oil/Trypsin Ointment without checking with your doctor.

  • If your wound does not improve or becomes worse, check with your doctor.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Balsam Peru/Castor Oil/Trypsin Ointment while you are pregnant. It is not known if Balsam Peru/Castor Oil/Trypsin Ointment is found in breast milk. If you are or will be breast-feeding while you use Balsam Peru/Castor Oil/Trypsin Ointment, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Balsam Peru/Castor Oil/Trypsin Ointment:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Temporary stinging.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Balsam Peru/Castor/Trypsin side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Balsam Peru/Castor Oil/Trypsin Ointment may be harmful if swallowed.


Proper storage of Balsam Peru/Castor Oil/Trypsin Ointment:

Store Balsam Peru/Castor Oil/Trypsin Ointment at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Do not store above 120 degrees F (49 degrees C). Store away from heat and direct sunlight. Do not store in the bathroom. Do not puncture, break, or burn the canister even if it appears to be empty. Keep Balsam Peru/Castor Oil/Trypsin Ointment out of the reach of children and away from pets.


General information:


  • If you have any questions about Balsam Peru/Castor Oil/Trypsin Ointment, please talk with your doctor, pharmacist, or other health care provider.

  • Balsam Peru/Castor Oil/Trypsin Ointment is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Balsam Peru/Castor Oil/Trypsin Ointment. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Balsam Peru/Castor Oil/Trypsin resources


  • Balsam Peru/Castor Oil/Trypsin Side Effects (in more detail)
  • Balsam Peru/Castor Oil/Trypsin Use in Pregnancy & Breastfeeding
  • Balsam Peru/Castor Oil/Trypsin Drug Interactions
  • Balsam Peru/Castor Oil/Trypsin Support Group
  • 1 Review for Balsam Peru/Castor/Trypsin - Add your own review/rating


Compare Balsam Peru/Castor Oil/Trypsin with other medications


  • Dermatologic Lesion

Thursday, 11 March 2010

Ebazam




Ebazam may be available in the countries listed below.


Ingredient matches for Ebazam



Clobazam

Clobazam is reported as an ingredient of Ebazam in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, 6 March 2010

Olux


Generic Name: clobetasol topical (kloe BAY ta sol)

Brand Names: Clobevate, Clobex, Cormax, Embeline E, Olux, Olux-E, Temovate


What is Olux (clobetasol topical)?

Clobetasol is a topical (for the skin) steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling.


Clobetasol topical is used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis.


Clobetasol topical may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Olux (clobetasol topical)?


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended. Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body.


Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with clobetasol topical can increase the amount of medicine your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions. Do not use this medication on a child without medical advice. Children are more likely to absorb large amounts of a topical steroid through the skin. Steroid absorption in children may cause unwanted side effects, or a delay in growth with long-term use. Talk with your doctor if you think your child is not growing at a normal rate while using this medication over a long treatment period. Contact your doctor if your condition does not improve within 2 weeks of using this medicine, or if you develop signs of a bacterial, fungal, or viral skin infection.

What should I discuss with my healthcare provider before using Olux (clobetasol topical)?


Do not use this medication if you are allergic to clobetasol.

To make sure you can safely take clobetasol topical, tell your doctor if you are allergic to any drugs, or if you have any type of skin infection.


Also tell your doctor if you have diabetes. Topical steroid medicines absorbed through the skin may increase the glucose (sugar) levels in your blood or urine.


FDA pregnancy category C. It is not known whether clobetasol topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. It is not known whether clobetasol topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medication on a child without medical advice. Children are more likely to absorb large amounts of a topical steroid through the skin. Steroid absorption in children may cause unwanted side effects, or a delay in growth with long-term use. Talk with your doctor if you think your child is not growing at a normal rate while using this medication over a long treatment period.

How should I use Olux (clobetasol topical)?


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended. Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body.


Wash your hands before and after using clobetasol topical, unless you are using the medication to treat the skin on your hands.

Apply a small amount to the affected area and rub it gently into the skin. Do not use this medication over a large area of skin.


Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with clobetasol topical can increase the amount of medicine your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions. Contact your doctor if your condition does not improve within 2 weeks of using this medicine, or if you develop signs of a bacterial, fungal, or viral skin infection. It is important to use clobetasol topical regularly to get the most benefit.

If you use this medication long-term, your blood will need to be tested often. Visit your doctor regularly.


Store at room temperature away from moisture and heat. Keep from freezing.

What happens if I miss a dose?


Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

An overdose of clobetasol is not expected to produce life-threatening symptoms. However, long-term use of high steroid doses can lead to symptoms such as thinning skin, easy bruising, changes in the shape or location of body fat (especially in your face, neck, back, and waist), increased acne or facial hair, menstrual problems, impotence, or loss of interest in sex.


What should I avoid while using Olux (clobetasol topical)?


Clobetasol topical should not be used to treat any skin condition your doctor has not prescribed it for.


Avoid using clobetasol topical to treat skin on your face, underarms, or groin area without your doctor's advice. Avoid getting this medication in your eyes. If contact does occur, rinse with water. Do not use clobetasol topical on broken or infected skin. Also avoid using this medication in open wounds.

Olux (clobetasol topical) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Although the risk of serious side effects is low when clobetasol topical is applied to the skin, you should be aware of side effects that can occur if the medication is absorbed into your bloodstream.


Stop using this medication and call your doctor at once if you have severe irritation of any treated skin, or if you show signs of absorbing clobetasol topical through your skin, such as:

  • blurred vision, or seeing halos around lights;




  • mood changes;




  • sleep problems (insomnia);




  • weight gain, puffiness in your face; or




  • muscle weakness, feeling tired.



Less serious side effects may include:



  • mild skin rash, itching, burning, or redness;




  • dry or cracking skin;




  • thinning or softening of your skin;




  • skin rash or irritation around your mouth;




  • swollen hair follicles;




  • temporary hair loss;




  • spider veins;




  • changes in color of treated skin;




  • blisters, pimples, or crusting of treated skin; or




  • stretch marks.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Olux (clobetasol topical)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied clobetasol topical. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Olux resources


  • Olux Side Effects (in more detail)
  • Olux Use in Pregnancy & Breastfeeding
  • Olux Drug Interactions
  • Olux Support Group
  • 7 Reviews for Olux - Add your own review/rating


  • Olux Prescribing Information (FDA)

  • Olux Foam MedFacts Consumer Leaflet (Wolters Kluwer)

  • Olux Advanced Consumer (Micromedex) - Includes Dosage Information

  • Clobex Lotion MedFacts Consumer Leaflet (Wolters Kluwer)

  • Clobex Prescribing Information (FDA)

  • Cormax Prescribing Information (FDA)

  • Embeline Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Olux-E Emollient Foam MedFacts Consumer Leaflet (Wolters Kluwer)

  • Olux-E Prescribing Information (FDA)

  • Temovate Prescribing Information (FDA)



Compare Olux with other medications


  • Atopic Dermatitis
  • Dermatitis
  • Lichen Planus
  • Lichen Sclerosus
  • Psoriasis


Where can I get more information?


  • Your pharmacist can provide more information about clobetasol topical.

See also: Olux side effects (in more detail)


Thiacetazone




Thiacetazone may be available in the countries listed below.


Ingredient matches for Thiacetazone



Thioacetazone

Thiacetazone (BAN) is also known as Thioacetazone (Rec.INN)

International Drug Name Search

Glossary

BANBritish Approved Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 4 March 2010

Mepyramine




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D04AA02,R06AC01

CAS registry number (Chemical Abstracts Service)

0000091-84-9

Chemical Formula

C17-H23-N3-O

Molecular Weight

285

Therapeutic Categories

Antiallergic agent

Histamine, H₁-receptor antagonist

Chemical Name

1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-

Foreign Names

  • Mepyraminum (Latin)
  • Mepyramin (German)
  • Mépyramine (French)
  • Mepiramina (Spanish)

Generic Names

  • Mepiramina (OS: DCIT)
  • Mepyramine (OS: BAN)
  • Mépyramine (OS: DCF)
  • Pyranisamine (IS)
  • Pyrilamin (IS)
  • Mepyramine Maleate (OS: BANM)
  • Pyrilamine Maleate (OS: USAN)
  • Mepyramon (IS)
  • Mépyramine (maléate de) (PH: Ph. Eur. 6)
  • Mepyramine Maleate (PH: BP 2010, Ph. Eur. 6)
  • Mepyraminhydrogenmaleat (PH: Ph. Eur. 6)
  • Mepyramini maleas (PH: Ph. Int. 2, Ph. Eur. 6)
  • Pyrilamine Maleate (PH: USP 32)
  • Mepifilina (IS)

Brand Names

  • Anthisan
    Aventis, Ghana; Aventis, Kenya; Aventis, Nigeria; Aventis, Uganda; Aventis, Zimbabwe; Sanofi-Aventis, Bangladesh; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Ireland; Sanofi-Aventis, Malta; Sanofi-Aventis, New Zealand; Winthrop, South Africa


  • Antihist
    Merck Generics, South Africa


  • Histavet P (veterinary use)
    Schering-Plough Animal Health, United States


  • Histodor (Mepyramine and Diphenhydramine)
    Aspen Pharmacare, South Africa


  • Mepyraderm
    Be-Tabs Pharmaceuticals, South Africa


  • Mepyramin SAD
    Amgros, Denmark


  • Mepyramine Maleate-Fresenius
    Bodene, South Africa


  • Mepyrimal
    Adcock Ingram Pharmaceuticals, South Africa


  • Nortussine (Mepyramine and Dextromethorphan)
    Norgine, France


  • Pyrilamine Maleate (veterinary use)
    Cross Vetpharm, United States


  • Fluidasa
    Bioresearch, Spain

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 3 March 2010

Maxudin




Maxudin may be available in the countries listed below.


Ingredient matches for Maxudin



Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Maxudin in the following countries:


  • Greece

International Drug Name Search

Aloxi


Aloxi is a brand name of palonosetron, approved by the FDA in the following formulation(s):


ALOXI (palonosetron hydrochloride - injectable; intravenous)



  • Manufacturer: HELSINN HLTHCARE

    Approval date: July 25, 2003

    Strength(s): EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) [RLD]


  • Manufacturer: HELSINN HLTHCARE

    Approval date: February 29, 2008

    Strength(s): EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) [RLD]

Has a generic version of Aloxi been approved?


No. There is currently no therapeutically equivalent version of Aloxi available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Aloxi. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Tricyclic 5-HT.sub.3 receptor antagonists
    Patent 5,202,333
    Issued: April 13, 1993
    Inventor(s): Berger; Jacob & Clark; Robin D. & Eglen; Richard M. & Smith; William L. & Weinhardt; Klaus K.
    Assignee(s): Syntex (U.S.A.) Inc.
    The present invention is directed to 5-HT.sub.3 receptor antagonist compounds of formula I: ##STR1## in which the dashed line denotes an optional double bond; n is 1, 2 or 3; p is 0, 1, 2 or 3; q is 0, 1 or 2; each R.sup.1 is independently selected from halogen, hydroxy, lower alkoxy, lower alkyl, nitro, amino, amino carbonyl, (lower alkyl)amino, di(lower alkyl)amino, and (lower alkanoyl)amino; each R.sup.2 is lower alkyl; and R.sup.3 is a group selected from Formulae (a), (b), (c) and (d): ##STR2## in which u is 0 or 1; z is 1, 2 or 3; and R.sup.4 is C.sub.1-7 alkyl, C.sub.3-8 cycloalkyl, C.sub.3-8 cycloalkyl-C.sub.1-2 alkyl, or a group (CH.sub.2).sub.t R.sup.5 where t is 1 or 2 and R.sup.5 is thienyl, pyrrolyl, or furyl, each optionally further substituted by one or two substituents selected from C.sub.1-6 alkyl, C.sub.1-6 alkoxy, trifluoromethyl or halogen, or is phenyl optionally substituted by one or two substituents selected from C.sub.1-4 alkoxy, trifluoromethyl, halogen, nitro, carboxy, esterified carboxy, and C.sub.1-4 alkyl optionally substituted by hydroxy, C.sub.1-4 alkoxy, carboxy, esterified carboxy or in vivo hydrolyzable acyloxy; and the pharmaceutically acceptable salts, individual isomers, mixtures of isomers, processes for preparation, compositions, and methods of use thereof.
    Patent expiration dates:

    • April 13, 2015
      ✓ 
      Patent use: PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
      ✓ 
      Drug substance
      ✓ 
      Drug product


    • April 13, 2015
      ✓ 
      Patent use: PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Liquid pharmaceutical formulations of palonosetron
    Patent 7,947,724
    Issued: May 24, 2011
    Inventor(s): Calderari; Giorgio & Bonadeo; Daniele & Cannella; Roberta & Braglia; Enrico & Braglia; Riccardo & Miksztal; Andrew & Malefyt; Thomas & Lee; Kathleen M.
    Assignee(s): Helsinn Healthcare S.A.
    Roche Palo Alto LLC
    The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Patent expiration dates:

    • January 30, 2024
      ✓ 
      Drug product




  • Liquid pharmaceutical formulations of palonosetron
    Patent 7,947,725
    Issued: May 24, 2011
    Inventor(s): Calderari; Giorgio & Bonadeo; Daniele & Cannella; Roberta & Braglia; Enrico & Braglia; Riccardo & Miksztal; Andrew & Malefyt; Thomas & Lee; Kathleen M.
    Assignee(s): Helsinn Healthcare S.A.
    Roche Palo Alto LLC
    The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Patent expiration dates:

    • January 30, 2024
      ✓ 
      Drug product




  • Liquid pharmaceutical formulations of palonosetron
    Patent 7,960,424
    Issued: June 14, 2011
    Inventor(s): Calderari; Giorgio & Bonadeo; Daniele & Cannella; Roberta & Braglia; Enrico & Braglia; Riccardo & Miksztal; Andrew & Malefyt; Thomas & Lee; Kathleen M.
    Assignee(s): Helsinn Healthcare S.A.
    Roche Palo Alto LLC
    The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
    Patent expiration dates:

    • January 30, 2024
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • March 1, 2011 - PREVENTION OF POST OPERATIVE NAUSEA AND VOMITING FOR UP TO 24 HOURS FOLLOWING SURGERY

    • March 1, 2011 - NEW STRENGTH

    • August 22, 2011 - NEW DOSAGE FORM

See also...

  • Aloxi Consumer Information (Drugs.com)
  • Aloxi Consumer Information (Wolters Kluwer)
  • Aloxi Capsules Consumer Information (Wolters Kluwer)
  • Aloxi Consumer Information (Cerner Multum)
  • Aloxi Advanced Consumer Information (Micromedex)
  • Aloxi AHFS DI Monographs (ASHP)
  • Palonosetron Consumer Information (Wolters Kluwer)
  • Palonosetron Capsules Consumer Information (Wolters Kluwer)
  • Palonosetron Consumer Information (Cerner Multum)
  • Palonosetron Advanced Consumer Information (Micromedex)
  • Palonosetron Intravenous Advanced Consumer Information (Micromedex)
  • Palonosetron Hydrochloride AHFS DI Monographs (ASHP)